Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 52, 2022 - Issue 7
227
Views
3
CrossRef citations to date
0
Altmetric
Articles

Ferric metformin drug complex supported on magnetic nanofiber cellulose; An efficient access to 4-H pyrans derivatives and determination of their antimicrobial activity

ORCID Icon, , ORCID Icon &
Pages 974-993 | Received 29 Oct 2021, Published online: 22 Apr 2022
 

Abstract

Magnetic nanofiber cellulose (NFC) was selected as a biopolymer surface for the reaction with ferric metformin and a novel nanocatalyst was prepared. This green heterogeneous organometallic catalyst was analyzed by physiochemical techniques. The new metformin drug complex supported on magnetic NFC was used as a powerful and efficient catalyst for the synthesis of functionalized 4H-pyrans derivatives. The antimicrobial activity of the products showed excellent activity against all the bacterial and fungal strains (especially compounds 7q and 6r).

Graphical Abstract

Acknowledgments

The authors are thankful to Iran National Science Foundation (INSF) and Sharif University of Technology Laboratory Services Center. Thanks to Dr. Zahra Daneshfar for helping us with this project.

Disclosure statement

The authors have no conflict of interest to declare.

Additional information

Funding

This work was supported by Iran National Science Foundation (INSF) and Sharif University of Technology Laboratory Services Center.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.